日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIII

TAK-754 的临床前开发,TAK-754 是一种基于 AAV8 的高性能载体,可表达凝血因子 VIII

Lengler, Johannes; Weiller, Markus; Horling, Franziska; Mayrhofer, Josef; Schuster, Maria; Falkner, Falko G; Gil-Farina, Irene; Klugmann, Matthias; Scheiflinger, Friedrich; Hoellriegl, Werner; Rottensteiner, Hanspeter

Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release

开发适用于临床产品上市的AAV8血友病B基因治疗载体的体外生物活性检测方法

Lengler, Johannes; Coulibaly, Sogue; Gruber, Bernadette; Ilk, Reinhard; Mayrhofer, Josef; Scheiflinger, Friedrich; Hoellriegl, Werner; Falkner, Falko G; Rottensteiner, Hanspeter

Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies

接种4剂肺炎球菌结合疫苗的儿童的抗体持久性和免疫记忆:两项长期随访研究的结果

Wysocki, Jacek; Brzostek, Jerzy; Konior, Ryszard; Panzer, Falko G; François, Nancy A; Ravula, Sudheer M; Kolhe, Devayani A; Song, Yue; Dieussaert, Ilse; Schuerman, Lode; Borys, Dorota

Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever

基于非复制型痘苗载体的黄热病实验疫苗的临床前疗效和安全性

Birgit Schäfer, Georg W Holzer, Alexandra Joachimsthaler, Sogue Coulibaly, Michael Schwendinger, Brian A Crowe, Thomas R Kreil, P Noel Barrett, Falko G Falkner

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations

基于改良安卡拉痘苗的大流行性流感 H1N1 活疫苗具有高度免疫原性,可在主动和被动免疫中保护小鼠

Annett Hessel, Michael Schwendinger, Daniela Fritz, Sogue Coulibaly, Georg W Holzer, Nicolas Sabarth, Otfried Kistner, Walter Wodal, Astrid Kerschbaum, Helga Savidis-Dacho, Brian A Crowe, Thomas R Kreil, P Noel Barrett, Falko G Falkner

Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus

针对 HR2 结构域和 S 蛋白 HR2 上游区域的单克隆抗体可中和严重急性呼吸综合征冠状病毒的体外感染

Kuo-Ming Lip, Shuo Shen, Xiaoming Yang, Choong-Tat Keng, Aihua Zhang, Hsueh-Ling Janice Oh, Zhi-Hong Li, Le-Ann Hwang, Chih-Fong Chou, Burtram C Fielding, Timothy H P Tan, Josef Mayrhofer, Falko G Falkner, Jianlin Fu, Seng Gee Lim, Wanjin Hong, Yee-Joo Tan